PLEKHG1: New Potential Candidate Gene for Periventricular White Matter Abnormalities

Francesco Calì1, Mirella Vinci1, Simone Treccarichi1

  • 1Oasi Research Institute-IRCCS, 94018 Troina, Italy.

Genes
|August 29, 2024
PubMed

Insights

A genetic variant in the PLEKHG1 gene may cause periventricular leukomalacia (PVL), a condition linked to cerebral palsy. This study identifies a de novo PLEKHG1 variant in a PVL patient, suggesting a new genetic cause for this brain damage.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Periventricular leukomalacia (PVL) is a significant cause of neurological deficits like cerebral palsy, particularly in preterm infants.
  • PVL results from compromised cerebral microcirculation, leading to oxygen deprivation in the brain's white matter.
  • Known causes include preterm birth, cotwin demise, and genetic factors affecting GTPase pathways.

Purpose of the Study:

  • To investigate the potential role of the PLEKHG1 gene in the pathogenesis of periventricular leukomalacia (PVL).
  • To identify and characterize genetic variants associated with PVL.
  • To explore the molecular mechanisms linking PLEKHG1 to white matter damage.

Main Methods:

  • Whole exome sequencing (WES) was employed to identify genetic variants in a patient with PVL.
  • In silico analyses were performed to predict the pathogenicity of the identified variant.
  • Literature review and pathway analysis were used to understand the functional role of PLEKHG1 and CDC42.

Main Results:

  • A de novo pathogenic variant in the PLEKHG1 gene was identified in a patient with PVL.
  • PLEKHG1 encodes a Rho guanine nucleotide exchange factor crucial for CDC42 activation.
  • The PLEKHG1-CDC42 pathway is implicated in endothelial cell responses to mechanical stress, potentially contributing to white matter lesions.

Conclusions:

  • The identified de novo PLEKHG1 variant is a plausible contributor to PVL, expanding the genetic landscape of this condition.
  • Disruption of the PLEKHG1-CDC42 pathway may underlie white matter damage in PVL.
  • Further research is warranted to fully elucidate the role of PLEKHG1 in neonatal brain injury.